The latest insights and news from Fullintel
When Abbott announced its FreeStyle Libre 3 device correction in November 2025, the company’s communications team had already established a verification website, deployed 24/7 customer support, and prepared replacement logistics. Seven deaths and 736 adverse events demanded nothing less. But the real test wasn’t the announcement, as îit was managing the narrative across global media, […]
Your legal team just forwarded a screenshot from r/technology. Three thousand upvotes on a post claiming your latest product update breaks user privacy. The thread, which is four hours old, has 847 comments and is now ranking on the first page of Google for “[your brand] privacy concerns.” This is the reality that PR teams […]
Every January, the JPM Healthcare Conference sets the tone for the year ahead in pharma and biotech. It’s where strategy meets scrutiny—where investors, analysts, media, and stakeholders look for credible signals about pipelines, leadership, innovation, and long-term growth. This year, I experienced JPM in person for the first time—and it reinforced just how much influence […]
A strong media monitoring report does more than recap yesterday’s headlines. It tells you what matters, why it matters, and what you should do next. For PR teams handling multichannel narratives, fast-moving crises, or complex stakeholder environments, these reports become the backbone of strategic communication. They help leaders make informed decisions, uncover risks early, and […]
The Truth Social post landed at 11:46 AM on Saturday, January 18. By noon, Novo Nordisk’s stock was dropping. By Monday morning, eight European countries faced new tariffs, pharmaceutical supply chains were in question, and PR teams across the industry were scrambling to explain what this meant for drug prices, manufacturing plans, and patient access. […]
Named experts beat anonymous brand content in the new citation economy. AI search tools—ChatGPT, Perplexity, and Google AI Overviews—increasingly evaluate who said something, not just where it appeared. Multiple studies confirm that content with credible author bylines, credentials, and first-hand expertise receives preferential citation over generic corporate content. For PR professionals, this represents a fundamental […]
AI-generated news summaries contain significant errors 45-60% of the time, according to major 2025 studies from the BBC/EBU and Columbia University’s Tow Center. This alarming error rate—combined with high-profile scandals, such as Deloitte’s refund of $291,000 for AI-generated citations—makes the case for human verification in executive briefings more compelling than ever. For pharmaceutical companies facing […]
Your CEO just asked ChatGPT which firms handle crisis communications for Fortune 500 companies. Your competitor appeared in the answer. You didn’t. This scenario plays out thousands of times daily across every industry. AI-powered search platforms now process over 2 billion queries per day, with ChatGPT alone handling this volume, and Google’s AI Overviews reaching […]
What were the top pharma news stories in January 2026? Three major pharmaceutical news stories dominated December 2025: the Trump administration’s proposed overhaul of childhood vaccine recommendations, voluntary drug pricing agreements under the Most Favored Nation policy, and the FDA’s qualification of AIM-NASH, the first AI tool for MASH clinical trials. January 2026 Pharma News […]
Large language models (LLMs) have transformed the way people search for and consume information. While traditional search engines like Google and Bing remain popular, nearly half of U.S. and European internet users now begin their search with some kind of AI tool. Even traditional search engines now utilize AI-generated summaries, sometimes leading to so-called “zero-click […]
